These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 665797)

  • 21. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
    Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
    J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of chronic haloperidol to affect prolactin secretion due to acute haloperidol administration.
    Parati EA; Parenti M; Locatelli V; Penalva A; Tamminga C; Müller EE
    Pharmacol Res Commun; 1985 May; 17(5):407-15. PubMed ID: 4034625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase.
    Bhargava HN
    Life Sci; 1984 Feb; 34(9):873-9. PubMed ID: 6142397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential alteration in striatal dopaminergic and cortical serotonergic receptors induced by repeated administration of haloperidol or centbutindole in rats.
    Gulati A; Srimal RC; Dhawan BN
    Pharmacology; 1988; 36(6):396-404. PubMed ID: 2901759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immuno-photoaffinity labeling of the D2-dopamine receptor.
    Kanety H; Fuchs S
    Biochem Biophys Res Commun; 1988 Sep; 155(2):930-6. PubMed ID: 2458727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.
    Gnegy M; Uzunov P; Costa E
    J Pharmacol Exp Ther; 1977 Sep; 202(3):558-64. PubMed ID: 19618
    [No Abstract]   [Full Text] [Related]  

  • 28. Aging and the regulation of striatal dopaminergic mechanisms in mice.
    Randall PK; Severson JA; Finch CE
    J Pharmacol Exp Ther; 1981 Dec; 219(3):695-700. PubMed ID: 7197719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.
    List SJ; Seeman P
    Life Sci; 1979 Apr; 24(16):1447-52. PubMed ID: 470544
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of long-term treatment with haloperidol and sulpiride on different types of dopaminergic receptors.
    Trabucchi M; Memo M; Battaini F; Reggiani A; Spano PF
    Adv Biochem Psychopharmacol; 1980; 24():275-81. PubMed ID: 7405667
    [No Abstract]   [Full Text] [Related]  

  • 31. Lack of effects of apomorphine, haloperidol and clozapine on the synthesis and utilization of brain GABA.
    Lindgren S
    J Neural Transm; 1987; 69(1-2):47-57. PubMed ID: 3585320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase of striatal dopamine turnover by drugs: interference with granular storage or receptor blackade?
    Saner A; Pletscher A
    Eur J Pharmacol; 1977 Mar; 42(2):155-60. PubMed ID: 844496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
    Schweitzer JW; Schwartz R; Friedhoff AJ
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of chronic clorgyline and amfonelic acid on desensitization of striatal dopamine receptors.
    Meller E; Bohmaker K; Friedhoff AJ
    Life Sci; 1984 Oct; 35(18):1829-38. PubMed ID: 6492992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of apomorphine on morphine analgesia during the state of dopaminergic supersensitivity after chronic treatment with haloperidol.
    Kamata K; Ogawa K; Noma S; Kameyama T
    J Pharmacobiodyn; 1986 Jan; 9(1):88-94. PubMed ID: 3712211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haloperidol prevents the methamphetamine-induced apomorphine subsensitivity of dopamine metabolism in rat striatum.
    Kashihara K; Fukuda K; Sato M; Otsuki S
    Neurosci Res; 1987 Jun; 4(5):428-32. PubMed ID: 3670749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unitary dopaminergic receptor composed of cooperatively linked agonist and antagonist sub-unit binding sites.
    Leysen JE
    Commun Psychopharmacol; 1979; 3(6):397-410. PubMed ID: 546588
    [No Abstract]   [Full Text] [Related]  

  • 39. Dopamine receptor binding in vivo: the feasibility of autoradiographic studies.
    Kuhar MJ; Murrin LC; Malouf AT; Klemm N
    Life Sci; 1978 Jan; 22(2):203-10. PubMed ID: 628311
    [No Abstract]   [Full Text] [Related]  

  • 40. Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid.
    Di Chiara G; Porceddu ML; Spano PF; Gessa GL
    Brain Res; 1977 Jul; 130(2):374-82. PubMed ID: 884534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.